Cardiology products
Ended Awarded Last action
- Contract number
- HT940625FGPC10
- Awardee
-
Boston Scientific Corp UEI YWDHHW3DLNQ1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $200,000
Award facts
- Contract value 100% obligated
- $200,000.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
About this award
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, received a Blanket Purchase Agreement (BPA) call award from the Defense Health Agency (DHA) on August 31, 2025, with a ceiling value of $200,000. The contract, which is firm fixed price in nature and not set-aside for any specific business category, covers cardiology products to be delivered from the contractor's Marlborough, MA facility. This award represents a task order or call against Boston Scientific's larger IDV with the DHA, demonstrating the company's established role as a critical supplier of specialized cardiovascular medical devices and solutions to the federal healthcare system.
The Defense Health Agency, which provides healthcare services to the Department of Defense and its beneficiaries, routinely awards such delivery orders to qualified vendors for essential medical equipment and supplies. Boston Scientific's extensive portfolio of federal contracts reflects the company's capability to provide advanced medical technologies including pacemakers, implantable cardioverter defibrillators, stents, catheters, and other interventional cardiology devices. With no set-aside designation, this contract award was made through open competition, underscoring Boston Scientific's competitive position in the federal medical device marketplace. The August 31, 2025 completion date indicates a near-term delivery requirement for the cardiology products needed to support DHA medical operations.
Quick answers
Who was awarded contract HT940625FGPC10?
HT940625FGPC10 was awarded to Boston Scientific Corp by Defense Health Agency (Department of Defense) on August 31, 2025.
How much is contract HT940625FGPC10 worth?
The government has obligated $200,000 on HT940625FGPC10.
Is contract HT940625FGPC10 an order under another contract?
Yes. HT940625FGPC10 is a BPA call under HT940623A0002, a blanket purchase agreement.
Was contract HT940625FGPC10 competed?
The extent of competition for HT940625FGPC10 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award